🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be the first repeat dose administration of GSK1322322 to in...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-05-11
Trial ID
NCT00896558
Treatments Being Tested
This study will determine the safety, tolerability and efficacy of GSK13223...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-08-17
Trial ID
NCT01209078
Treatments Being Tested
The primary objectives of this study are to assess the safety, tolerability...
Status
Terminated
Location
GSK Investigational Site
Start Date
2013-08-07
Trial ID
NCT01818011
This is a randomized, partially-blinded, placebo and moxifloxacin-controlle...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT01803399
Treatments Being Tested
This first time in human (FTIH) study will be the first administration of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-09-13
Trial ID
NCT01610388
This study is being conducted to confirm that GSK1322322 has no negative im...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT01953809
Treatments Being Tested